Pharma Giant's TB Drug Decision Welcomed, But Not All Developing Countries Benefit
22 July 2023, 08:15 
BRATISLAVA, Jul 21 (IPS) - In a surprise move, pharma giant Johnson and Johnson (J&J) has agreed not to enforce some of its patents on a lifesaving TB drug, making generic versions available in many low- and middle-income countries (LMICs).
Source:
Global Issues News Headlines
Comments (0)
Do you like the page?
Would you like to share the page with your friends?